AI assistant
PFIZER INC — Director's Dealing 2011
Mar 1, 2011
29831_dirs_2011-02-28_721437d2-7b18-45cc-b58b-4c235a1fabc0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2011-02-24
Reporting Person: HILL CHARLES H (Executive Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-02-24 | Common Stock | A | 17867.0000 | $0.0000 | Acquired | 62545.0000 | Direct |
| 2011-02-24 | Common Stock | A | 1339.0000 | $0.0000 | Acquired | 63884.0000 | Direct |
| 2011-02-24 | Common Stock | F | 486.0000 | $18.9000 | Disposed | 63398.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-02-24 | Stock Appreciation Rights | $18.9000 | A | 78855.0000 | Acquired | 2016-02-24 | Common Stock (78855.0000) | Direct |
| 2011-02-24 | Stock Appreciation Rights | $18.9000 | A | 65280.0000 | Acquired | 2018-02-24 | Common Stock (65280.0000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 183.0000 | Indirect |
Footnotes
F1: The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements.
F2: The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon).
F3: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance Share Awards (including dividend equivalents thereon).
F4: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.
F5: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.